21
Jun
Impact Guru, one of India’s foremost medical crowdfunding platforms, has initiated an urgent campaign to raise ₹9 crore for 5-month-old Anshika Mandal, who is battling Spinal Muscular Atrophy (SMA) Type 1 — a rare and fatal genetic disorder. The funds are required to administer Zolgensma, a one-time gene therapy considered the most effective treatment for the condition. Anshika, the only child of Bitapi and Animesh Mandal, has been struggling with basic motor functions since birth. Without immediate intervention, children with SMA Type 1 rarely survive beyond the age of two. “Every day I watch my daughter try to cry but…
